Display options
Share it on

Curr Colorectal Cancer Rep. 2014 Dec 01;10(4):417-424. doi: 10.1007/s11888-014-0253-2.

Histone Demethylases in Colon Cancer.

Current colorectal cancer reports

Santanu Paul, Satish Ramalingam, Dharmalingam Subramaniam, Joaquina Baranda, Shrikant Anant, Animesh Dhar

Affiliations

  1. Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas.
  2. Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas.
  3. Hematology & Oncology, University of Kansas Medical Center, Kansas City, Kansas.
  4. Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas ; Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas.

PMID: 25574158 PMCID: PMC4283932 DOI: 10.1007/s11888-014-0253-2

Abstract

Cell growth and proliferation are controlled through different posttranslational modifications including demethylation, a process regulated by regulated by the demethylase enzymes. This review focuses on our current understanding of functional and therapeutic potentials of histone demethylases in colon cancer. Colon cancer is the third most common malignancy worldwide and the second leading cause of cancer deaths in the United States. The key protein families responsible for demethylation of histones, histone demethylases, have emerged as new therapeutic targets in different cancer types including colon cancer. These families are of great interest as potential novel biomarkers for diagnosis and targets for therapy and prevention of colon cancer. In this manuscript, we will discuss our current understanding of the histone demethylase family, and the role they play as epigenetic activators or repressors of different genes in colon cancer.

Keywords: Colon Cancer; Epigenetic; Histone Lysine Demethylases; JMJD; KDM; LSD

References

  1. PLoS One. 2012;7(4):e35065 - PubMed
  2. J Biol Chem. 2004 Dec 10;279(50):52353-60 - PubMed
  3. Hum Mol Genet. 2011 Dec 1;20(23 ):4655-65 - PubMed
  4. Mol Cell. 2007 Mar 23;25(6):801-12 - PubMed
  5. Nat Genet. 2009 Jan;41(1):125-9 - PubMed
  6. Nature. 2006 Feb 16;439(7078):811-6 - PubMed
  7. J Pathol. 2005 Jan;205(2):130-44 - PubMed
  8. Science. 2004 Oct 8;306(5694):279-83 - PubMed
  9. Cell. 2006 May 5;125(3):467-81 - PubMed
  10. PLoS One. 2013 Jul 26;8(7):e70077 - PubMed
  11. Mol Cell. 2010 Jul 9;39(1):152-60 - PubMed
  12. Cell. 2002 Nov 1;111(3):281-4 - PubMed
  13. EMBO Rep. 2005 Apr;6(4):315-20 - PubMed
  14. Semin Cell Dev Biol. 2010 Apr;21(2):209-20 - PubMed
  15. Cell. 2004 Aug 6;118(3):277-9 - PubMed
  16. Trends Cell Biol. 2010 Nov;20(11):662-71 - PubMed
  17. Cancer Lett. 2011 Dec 1;311(1):66-76 - PubMed
  18. Cancer Res. 2009 Mar 1;69(5):2065-71 - PubMed
  19. Int J Cancer. 2012 Sep 15;131(6):1423-34 - PubMed
  20. Clin Cancer Res. 2010 Sep 15;16(18):4636-46 - PubMed
  21. Nat Rev Drug Discov. 2013 Dec;12(12):917-30 - PubMed
  22. J Biol Chem. 2010 Sep 24;285(39):30034-41 - PubMed
  23. Int J Cancer. 2011 Feb 1;128(3):574-86 - PubMed
  24. Cell. 2002 Jun 28;109(7):801-6 - PubMed
  25. Br J Cancer. 2013 Aug 20;109(4):994-1003 - PubMed
  26. Nature. 2005 Sep 15;437(7057):436-9 - PubMed
  27. Dig Dis Sci. 2013 Jun;58(6):1581-9 - PubMed
  28. Biochem J. 2013 Jan 15;449(2):459-68 - PubMed
  29. Biol Reprod. 2007 Nov;77(5):754-64 - PubMed
  30. J Med Chem. 2014 Jan 9;57(1):42-55 - PubMed
  31. Cell. 2009 Aug 21;138(4):660-72 - PubMed
  32. Science. 2002 Nov 29;298(5599):1747-52 - PubMed
  33. Cell. 2004 Dec 29;119(7):903-6 - PubMed
  34. Genes Dev. 2006 Jun 1;20(11):1394-404 - PubMed
  35. Mol Pharmacol. 2011 Jan;79(1):197-206 - PubMed
  36. Oncogene. 2012 Nov 29;31(48):5007-18 - PubMed
  37. Nature. 2005 Sep 15;437(7057):432-5 - PubMed
  38. J Biol Chem. 2007 May 25;282(21):15471-5 - PubMed
  39. Nature. 2002 Sep 12;419(6903):178-82 - PubMed
  40. Mol Cell. 2005 Sep 16;19(6):857-64 - PubMed
  41. J Med Chem. 2010 Aug 12;53(15):5629-38 - PubMed
  42. J Biol Chem. 2010 Sep 24;285(39):29676-80 - PubMed
  43. Hum Mol Genet. 2003 Aug 1;12(15):1783-90 - PubMed
  44. Proc Natl Acad Sci U S A. 2007 May 8;104(19):8023-8 - PubMed
  45. Cancer Res. 2011 Feb 1;71(3):655-60 - PubMed
  46. Cancer Res. 2013 Jan 1;73(1):235-45 - PubMed
  47. Nat Rev Cancer. 2008 May;8(5):387-98 - PubMed
  48. Structure. 2011 Feb 9;19(2):212-20 - PubMed
  49. ACS Chem Biol. 2012 Jul 20;7(7):1221-31 - PubMed
  50. Cell. 2004 Dec 29;119(7):941-53 - PubMed
  51. Nat Med. 2012 Mar 11;18(4):605-11 - PubMed
  52. Biochem Pharmacol. 2000 Oct 15;60(8):1091-9 - PubMed
  53. Mol Cell Biol. 2010 Oct;30(20):4851-63 - PubMed
  54. Pharmaceuticals (Basel). 2012 Sep 12;5(9):963-90 - PubMed
  55. Nature. 2001 Nov 15;414(6861):277-83 - PubMed
  56. Nature. 2003 Oct 2;425(6957):516-21 - PubMed
  57. Nature. 2000 Feb 3;403(6769):501-2 - PubMed
  58. Stem Cells. 2011 May;29(5):791-801 - PubMed
  59. Eur J Cell Biol. 2010 Jul;89(7):557-63 - PubMed
  60. J Med Chem. 2010 Feb 25;53(4):1810-8 - PubMed
  61. Nature. 2007 Sep 6;449(7158):105-8 - PubMed
  62. Science. 2001 Aug 10;293(5532):1074-80 - PubMed
  63. Nat Rev Mol Cell Biol. 2005 Nov;6(11):838-49 - PubMed
  64. Mol Carcinog. 2011 Dec;50(12):931-44 - PubMed
  65. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29 - PubMed
  66. Br J Cancer. 2008 Dec 2;99(11):1900-7 - PubMed
  67. Mol Cell. 2007 Apr 27;26(2):160-2 - PubMed
  68. Cell. 2006 Nov 3;127(3):469-80 - PubMed
  69. Carcinogenesis. 2010 Mar;31(3):512-20 - PubMed
  70. Cell. 2006 Apr 21;125(2):213-7 - PubMed
  71. Pathobiology. 2006;73(5):213-23 - PubMed
  72. EMBO J. 2010 Jun 2;29(11):1803-16 - PubMed
  73. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17216-21 - PubMed

Publication Types

Grant support